Hidradenitis Suppurativa August 22, 2025 By Rebecca Dotterweich Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1) More Details Filed Under: More from Department of Dermatology Dermatopathology Fellowship Protected: Toronto GEM Meeting: Jul 27–29, 2009 Residency Training Program